企業プロフィール
FEMASYS 株価・ニュース・カタリスト
- ティッカー:
- FEMY
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
2.16 USD (-5.68%)
終値
最終更新: 2026年8月17日
22.4M USD
時価総額
株価変動の要因
Following the latest company update, “Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update”, FEMY closed down 5.68% at $2.16 on Aug 17, 2026. The move occurred in the trading session associated with this earnings update.
企業概要
事業概要
Femasys is a women’s health medical technology company focused on fertility and reproductive-health products. Its business is centered on procedures and devices that address unmet needs in women’s health.
所在地とセクター分類
Femasys is headquartered in the United States and listed on NASDAQ. It sits in women’s-health medtech rather than biotechnology.
ビジネスモデルの特徴
The company depends on product adoption, physician acceptance, and regulatory or commercial milestones. Investors watch launch execution, reimbursement, and the pace of market penetration.
バイオ業界での位置付け
Femasys occupies a women’s-health device niche within healthcare innovation. It is not biotech proper, but its growth still depends on product adoption and clinical credibility.
今後のカタリスト
- Femasys’s catalysts are FemBloc commercialization and women’s-health product development, where adoption and regulatory progress matter most. The company needs to show the platform can translate into real clinical use.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。